(HealthDay)—A new class of sleep medications appears to help people fall asleep without causing grogginess the next day, researchers say.
Medical research Apr 03, 2013 | 4.5 / 5 (6) | 1 |
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Medications May 21, 2013 | 4.2 / 5 (5) | 0
A vaccine against cervical cancer, being developed by Inovio Pharmaceuticals Inc. of Blue Bell, Pa., produced positive results in a small sample of 18 women.
Cancer Oct 12, 2012 | 5 / 5 (3) | 0
Many consumers mistakenly believe new prescription drugs are always safer than those with long track records, and that only extremely effective drugs without major side effects win government approval, according to a new ...
Medications Sep 12, 2011 | 3 / 5 (3) | 0
(HealthDay) -- Two Merck & Co. drugs -- one to treat hair loss in men, the other to treat an enlarged prostate gland -- will get revised labels warning of potential sexual side effects that can last even after ...
Medications Apr 12, 2012 | 4.5 / 5 (2) | 0
(HealthDay)—Combination treatment with fenofibrate and simvastatin (FENO-S) significantly reduces postprandial (PP) triglyceride (TG) levels compared with simvastatin alone in all subjects, regardless of ...
Diabetes Nov 01, 2012 | 4.5 / 5 (2) | 0
For Alzheimer's patients and their families, desperate for an effective treatment for the epidemic disease, there's hope from new studies starting up and insights from recent ones that didn't quite pan out.
Alzheimer's disease & dementia Dec 03, 2012 | 5 / 5 (1) | 0
(HealthDay)—The cervical cancer vaccine has turned into one of the biggest success stories in the field.
Cancer Jan 19, 2013 | 5 / 5 (1) | 0
The results of a national online study show that 45% consider their parents to be their sexuality role model. Shattering stereotypes that parents and society hold about teen sexuality, the survey also revealed that only 32% ...
Health Jun 15, 2011 | 4 / 5 (1) | 0
A combination drug containing niacin failed to lower the risk of heart attacks or strokes and even proved harmful for some with vascular disease, a study released Saturday reported.
Cardiology Mar 09, 2013 | 4 / 5 (1) | 0
Merck KGaA saw its profit more than double in the fourth quarter as the German pharmaceutical company benefited from higher prices for its Rebif multiple sclerosis drug and reaped rewards from its ongoing restructuring.
Other Mar 07, 2013 | 2 / 5 (1) | 0
Drugmaker Merck says it is suspending its sale of the cholesterol drug Tredaptive and is telling doctors to quit prescribing the medicine.
Medications Jan 11, 2013 | 1 / 5 (1) | 0